Table 2.
Adjusted odds ratios of 28-day mortality associated with elevated shock index (≥0.7) relative to shock index <0.7, among patients admitted with non-ST-segment elevation myocardial infarction
| Model adjustmenta | OR (95% CI) |
|---|---|
| Crude | 2.89 (2.24–3.69) |
| Demographics | 2.77 (2.15–3.59) |
| Demographics, comorbidities | 2.46 (1.81–3.33) |
| Demographics, comorbidities, therapies | 2.02 (1.46–2.80) |
The community surveillance component of the Atherosclerosis Risk in Communities Study, 2000–2014.
a
Demographics = age, race, sex, and year of hospital admission. Comorbidities = smoking, diabetes mellitus, chronic kidney disease, prior coronary revascularization, and history of stroke. Therapies = aspirin, antiplatelets, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, lipid-lowering medications, and coronary revascularization either by percutaneous coronary intervention or by coronary artery bypass graft.